Skip to content

CROI: AZT, 3TC and FTC achieve good concentrations in the female genital tract; good candidates for PrEP?

News from the Thirteenth Conference on Retroviruses and Opportunistic Infections

Bristol Myers Squibb announces voluntary licenses for atazanavir in India and South Africa

CROI: Cotrimoxazole prophylaxis reduces adverse birth outcomes in Zambian women with HIV

CROI: Male circumcision reduces risk of transmission of HIV and some STIs to female partners

CROI: Two studies show single-dose nevirapine prevents HIV transmission in consecutive pregnancies

CROI: Abacavir gene testing reveals high levels of hypersensitivity mutation

CROI: Etravirine (TMC125) and darunavir (TMC114) in treatment-experienced patients

CROI: Atazanavir and atazanavir/ritonavir safe and effective in treatment-naive patients